• Complain

Nima Rezaei - Coronavirus Disease - COVID-19

Here you can read online Nima Rezaei - Coronavirus Disease - COVID-19 full text of the book (entire story) in english for free. Download pdf and epub, get meaning, cover and reviews about this ebook. year: 2021, publisher: Springer International Publishing, genre: Romance novel. Description of the work, (preface) as well as reviews are available. Best literature library LitArk.com created for fans of good reading and offers a wide selection of genres:

Romance novel Science fiction Adventure Detective Science History Home and family Prose Art Politics Computer Non-fiction Religion Business Children Humor

Choose a favorite category and find really read worthwhile books. Enjoy immersion in the world of imagination, feel the emotions of the characters or learn something new for yourself, make an fascinating discovery.

Nima Rezaei Coronavirus Disease - COVID-19
  • Book:
    Coronavirus Disease - COVID-19
  • Author:
  • Publisher:
    Springer International Publishing
  • Genre:
  • Year:
    2021
  • Rating:
    3 / 5
  • Favourites:
    Add to favourites
  • Your mark:
    • 60
    • 1
    • 2
    • 3
    • 4
    • 5

Coronavirus Disease - COVID-19: summary, description and annotation

We offer to read an annotation, description, summary or preface (depends on what the author of the book "Coronavirus Disease - COVID-19" wrote himself). If you haven't found the necessary information about the book — write in the comments, we will try to find it.

Nima Rezaei: author's other books


Who wrote Coronavirus Disease - COVID-19? Find out the surname, the name of the author of the book and a list of all author's works by series.

Coronavirus Disease - COVID-19 — read online for free the complete book (whole text) full work

Below is the text of the book, divided by pages. System saving the place of the last page read, allows you to conveniently read the book "Coronavirus Disease - COVID-19" online for free, without having to search again every time where you left off. Put a bookmark, and you can go to the page where you finished reading at any time.

Light

Font size:

Reset

Interval:

Bookmark:

Make
Contents
Landmarks
Book cover of Coronavirus Disease - COVID-19 Volume 1318 Advances in - photo 1
Book cover of Coronavirus Disease - COVID-19
Volume 1318
Advances in Experimental Medicine and Biology
Series Editors
Wim E. Crusio
Institut de Neurosciences Cognitives et Intgratives dAquitaine, CNRS and University of Bordeaux, Pessac Cedex, France
Haidong Dong
Departments of Urology and Immunology, Mayo Clinic, Rochester, MN, USA
Heinfried H. Radeke
Institute of Pharmacology & Toxicology, Clinic of the Goethe University Frankfurt Main, Frankfurt am Main, Hessen, Germany
Nima Rezaei
Research Center for Immunodeficiencies, Childrens Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Junjie Xiao
Cardiac Regeneration and Ageing Lab, Institute of Cardiovascular Sciences, School of Life Science, Shanghai University, Shanghai, China

Advances in Experimental Medicine and Biology provides a platform for scientific contributions in the main disciplines of the biomedicine and the life sciences. This series publishes thematic volumes on contemporary research in the areas of microbiology, immunology, neurosciences, biochemistry, biomedical engineering, genetics, physiology, and cancer research. Covering emerging topics and techniques in basic and clinical science, it brings together clinicians and researchers from various fields.

Advances in Experimental Medicine and Biology has been publishing exceptional works in the field for over 40 years, and is indexed in SCOPUS, Medline (PubMed), Journal Citation Reports/Science Edition, Science Citation Index Expanded (SciSearch, Web of Science), EMBASE, BIOSIS, Reaxys, EMBiology, the Chemical Abstracts Service (CAS), and Pathway Studio.

2019 Impact Factor: 2.450 5 Year Impact Factor: 2.324

More information about this series at http://www.springer.com/series/5584

Editor
Nima Rezaei
Coronavirus Disease - COVID-19
1st ed. 2021
Logo of the publisher Editor Nima Rezaei MD PhD Research Center for - photo 2
Logo of the publisher
Editor
Nima Rezaei MD, PhD
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
ISSN 0065-2598 e-ISSN 2214-8019
Advances in Experimental Medicine and Biology
ISBN 978-3-030-63760-6 e-ISBN 978-3-030-63761-3
https://doi.org/10.1007/978-3-030-63761-3
The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021
This work is subject to copyright. All rights are solely and exclusively licensed by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This Springer imprint is published by the registered company Springer Nature Switzerland AG

The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland

This book would not have been possible without the continuous encouragement of my family.

I wish to dedicate it to my daughters, Ariana and Arnika, with the hope that we learn enough from today to make a brighter future for the next generation.

This book is also dedicated to honoring the memory of our brave fallen doctors and nurses who fought against COVID-19.

Preface
On March 2 2020 I had an hour-long meeting with three of my colleagues - photo 3

On March 2, 2020, I had an hour-long meeting with three of my colleagues, including the head of the hospital, head of infant intensive care unit (ICU), and the consultant of the hospital, at the head office of the Childrens Medical Center, the Pediatrics Center of Excellence (Tehran, Iran), to discuss the novel coronavirus disease 2019 (COVID-19) outbreak. A few days later, I realized that all of them were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), confirmed by real-time RT PCR (rRT-PCR) assays. Two of them presented with only low-grade fever and malaise, while the third one suffered from anosmia in addition to cough and myalgia. So, it raised several questions in my mind, while I also had some concerns about being affected by SARS-CoV-2, not only because of that meeting with three physicians who were positive for the virus, but also for meeting and talking closely with two other faculty members of our hospital, who were both recently infected by COVID-19. So, am I positive for COVID-19? Fortunately, in the 2 weeks after that meeting and after 8 months of working in the pediatric referral hospital during the pandemic, I had not presented any symptom of the disease, until October 2020, when I faced headache, backache, chills, and malaise, which made me to qurantine myself for 18 days. As I was quite sure about my symptoms, I did not test for SARS-CoV-2 during my quarantine. However, SARS-CoV-2 IgG had been incresead slightly, when I got back to the hospital. So, I am not among more than a hundred million of reported cases, which might show that the number of COVID-19 is understimated!

Meanwhile, the global challenges and concerns still remain, while many questions are yet to be answered! Is being asymptomatic not equal to being affected? How does the virus spread? Does the outbreak situation change by weather in different seasons? Who are at a higher risk of infection and mortality? Are healthy individuals without any underlying disease protected!? How can we protect ourselves? And the immune system: Friend or Foe?

We, the world outside of China, heard the news of a Chinese city affected by pneumonia of unknown origin in December 2019. We also saw this city, in response to the increasing number of patients presented with this unusual pneumonia, construct a temporary hospital in less than 2 weeks, but did not realize that this disease could spread far beyond its boundaries, strike near us, and provide an experience far worse than what happened in the city when affected the first time. Wuhan was that city, and with the discovery of a coronavirus as the pathogen behind that, COVID-19 was the name assigned to that unusual pneumonia.

This novel SARS-CoV-2 proved to be unique in terms of transmissibility and mortality. A proof of its being highly contagious is that while we were all obsessed with the movement of the SARS-CoV-2 from Wuhan to all territories worldwide, it has been very difficult for most of us to track the chronological order of its global spread after affecting Wuhan. However, its consequences are hitting us; 5 months have passed since the the World Health Organization (WHO) declared COVID-19 a pandemic on March 11, 2020, while many countries are fighting the first and second wave of the disease. It should be mentioned that there were only about 100,000 diagnosed cases within a 3-month period since the beginning of the outbreak; in the month of April, about 3 million new cases were reported; now, there are more than 120 million officially reported cases and more than 2.5 million deaths from all over the world (mid-March 2021); and it's still unclear when the pandemic will end! The pandemic has profoundly affected not only human health but also human behavior and thought. No curative therapy so far! One of my aforementioned colleagues, who was positive for SARS-CoV-2 in March 2020 and cured, faced reinfection 2 months later with positive PCR again! There are some other reports, especially from healthcare workers who are exhausted from the continuous long-term fight against COVID-19, which shows the potential risk of reinfection after decreasing the SARS-CoV-2 antibody level. So, how effective will the vaccines be?

Next page
Light

Font size:

Reset

Interval:

Bookmark:

Make

Similar books «Coronavirus Disease - COVID-19»

Look at similar books to Coronavirus Disease - COVID-19. We have selected literature similar in name and meaning in the hope of providing readers with more options to find new, interesting, not yet read works.


Reviews about «Coronavirus Disease - COVID-19»

Discussion, reviews of the book Coronavirus Disease - COVID-19 and just readers' own opinions. Leave your comments, write what you think about the work, its meaning or the main characters. Specify what exactly you liked and what you didn't like, and why you think so.